Related Experiment Video

Updated: Jun 12, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

[Increased prevalence of depression in hepatitis C infection patients]

Simon Hjerrild1, Signe Groth Renvillard, Peter Derek Christian Leutscher

  • 1Center for Psykiatrisk Forskning, Arhus Universitetshospital, Risskov, 8240 Risskov, Denmark. bauhjerrild@gmail.com

Ugeskrift for Laeger
|June 24, 2010
PubMed

Insights

Depression is more common in patients with chronic hepatitis C virus (HCV) infection. Early diagnosis and treatment of depression are crucial for effective HCV management and antiviral therapy.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Psychiatry

Background:

  • Increased prevalence of depression observed in patients with chronic hepatitis C virus (HCV) infection.
  • Potential etiological factors include psychiatric history, genetic predisposition, socioeconomic factors, stigma, and HCV neuroinfection.
  • Lack of evidence linking past intravenous drug use to increased depression risk in HCV patients.

Purpose of the Study:

  • To investigate the prevalence and potential causes of depression in chronic hepatitis C virus (HCV) infected patients.
  • To highlight the importance of diagnosing and treating depression in this population.

Main Methods:

  • Review of existing literature on depression in HCV patients.
  • Analysis of potential etiological factors.
  • Assessment of the impact of depression on antiviral treatment.

Main Results:

  • Depression is significantly more prevalent in individuals with chronic HCV infection.
  • Multiple factors contribute to depression, with neuroinfection and premorbid conditions being key considerations.
  • Depression acts as a contraindication to antiviral therapy and can negatively impact treatment outcomes.

Conclusions:

  • Depression is a significant comorbidity in chronic hepatitis C virus (HCV) infection.
  • Addressing depression is essential for successful HCV treatment and patient well-being.
  • Further research is needed to fully elucidate the neurobiological mechanisms of HCV-associated depression.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...